Diffuse intrinsic pontine glioma (DIPG) remains intractable to conventional treatments. While targeted therapy and immuno-oncology advances offer hope, few strategies show promising results. In a recent article in Cancer Cell, Ausejo-Mauleon et al. introduce TIM-3 blockade as a potential breakthrough for DIPG treatment by targeting cancer cells and regulating the immune microenvironment simultaneously.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.molmed.2023.11.014 | DOI Listing |
Publication Analysis
Top Keywords
tim-3 blockade
8
targeted therapy
8
blockade immune
4
immune targeted
4
therapy dipg
4
dipg diffuse
4
diffuse intrinsic
4
intrinsic pontine
4
pontine glioma
4
glioma dipg
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!